{"gao_id": "GAO-14-68", "published": "2013-12-19T12:00:00Z", "released": "2014-02-06T07:00:00Z", "summary": "", "title": "Medicaid Prescription Drugs: CMS Should Implement Revised Federal Upper Limits and Monitor Their Relationship to Retail Pharmacy Acquisition Costs [Reissued on February 6, 2014]", "topics": ["Surveys", "Reimbursements", "Monitoring", "Medicaid", "Retail facilities", "Beneficiaries", "Federal funds", "Pharmaceutical industry", "Outpatient care", "Data collection", "Invoices", "Health Care", "Documentation", "Prescription drugs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-14-68", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-14-68-highlights.pdf"}, {"title": "Full Report (46 pages)", "url": "https://www.gao.gov/assets/gao-14-68.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/670/660303.txt"}]}